Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2006
10/05/2006CA2603122A1 Phenyl and pyridyl lta4h modulators
10/05/2006CA2603094A1 Substituted pyrazolyl oxyphenyl derivatives used as herbicides
10/05/2006CA2602510A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
10/05/2006CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
10/05/2006CA2602254A1 Pharmacokinetically improved compounds
10/05/2006CA2602250A1 Pyridine derivatives useful as inhibitors of pkc-theta
10/04/2006EP1707563A2 Methods and compositions utilizing quinazolinones
10/04/2006EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
10/04/2006EP1707205A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
10/04/2006EP1706402A1 Cathepsin cysteine protease inhibitors
10/04/2006EP1706400A1 Phenyl- 4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl -amine derivatives as igf-ir inhibitors
10/04/2006EP1706399A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
10/04/2006EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors
10/04/2006EP1706397A2 Novel amorphous form of omeprazole salts
10/04/2006EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
10/04/2006EP1706388A1 Therapeutic agents ii
10/04/2006EP1706385A1 Pyrazole derivatives as protein kinase modulators
10/04/2006EP1706384A1 Therapeutic agents i
10/04/2006EP1706380A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/04/2006EP1706379A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/04/2006EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
10/04/2006EP1705989A1 Substituted arylpyrazoles as parasiticidal agents
10/04/2006EP1527067B1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
10/04/2006EP1492786B1 Pyridinoylpiperidines as 5-ht1f agonists
10/04/2006EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors
10/04/2006EP1385840B1 Sulfonamides
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
10/04/2006EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
10/04/2006EP0898568B1 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
10/04/2006EP0893446B1 Cephem compounds and drugs containing the compounds
10/04/2006CN1842526A Benzodiazepine CGRP receptor antagonists
10/04/2006CN1842525A Barium salt of benzimidazole derivative
10/04/2006CN1842524A 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
10/04/2006CN1277824C Piperazine derivatives
10/04/2006CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B
10/04/2006CN1277528C Dyeing composition for kerationous fibres comprising particular dicationic diazo dye
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115749 For inhibiting hepatitis c virus RNA-dependent polymerase
10/03/2006US7115744 Method for producing 8-methoxy-quinolinecarboxylic acids
10/03/2006US7115739 Triazole compounds useful as protein kinase inhibitors
10/03/2006US7115664 Peptidomimetic ligands for cellular receptors and ion channels
10/03/2006US7115652 Aspartyl protease inhibitors
10/03/2006US7115646 Cyclic diamines and derivatives as factor Xa inhibitors
10/03/2006US7115645 Central nervous system disorders; antiinflammatory agents
10/03/2006US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents
10/03/2006US7115637 Inhibitors of p38
10/03/2006US7115636 use as antiviral agents; treatment of cytomegalovirus infection
10/03/2006US7115635 Benzylpiperidine compound
10/03/2006US7115634 4-aminopiperidine and their use as a medicine
10/03/2006US7115632 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/03/2006US7115630 Metabotropic glutamate receptor antagonists
10/03/2006US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction
10/03/2006US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants
10/03/2006US7115616 Pyrimidinone compounds
10/03/2006US7115609 Compounds containing particular phenyl, indolyl or benzo[b]thiophenyl groups, a glycine residue bearing a substituted alkyl group and a 4-(1-methyl-piperidin-4-yl)piperidin-1-yl or 4-(1-methylpiperidin-4-yl)piperazin-1-yl group; Factor Xa inhibitors, thrombotic disorder
10/03/2006US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
10/03/2006US7115603 A1-pyrrolines
10/03/2006US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS
10/03/2006US7115600 Histamine-3 receptor modulators
10/03/2006US7115596 Thiazole compounds as integrin receptor antagonists derivatives
10/03/2006US7115544 Plant growth regulators for cotton hervest
10/03/2006CA2474211C Antiproliferative quinazolines
10/03/2006CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them
10/03/2006CA2288241C Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
10/03/2006CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions
10/03/2006CA2277018C Use of angiotensin ii antagonists to treat symptomatic heart failure
10/03/2006CA2187130C Novel sulphonamides
09/2006
09/28/2006WO2006102645A1 Biaryl derived amide modulators of vanilloid vr1 receptor
09/28/2006WO2006102025A1 Conversion of 2-pyrazolines to pyrazoles using bromine
09/28/2006WO2006101859A2 Piperidinyl substituted cyclohexane-1,4-diamines
09/28/2006WO2006101808A1 Pyrrolidine derivatives as histamine h3 receptor antagonists
09/28/2006WO2006101780A1 Mitotic kinesin inhibitors
09/28/2006WO2006101603A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
09/28/2006WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative
09/28/2006WO2006100922A1 Cinnamoyl compound and use thereof
09/28/2006WO2006100588A1 Substituted triazole derivatives as oxytocin antagonists
09/28/2006WO2006100565A1 Crystalline forms of a known pyrrolidine factor xa inhibitor
09/28/2006WO2006100557A1 Substituted triazole derivatives as oxytocin antagonists
09/28/2006WO2006100243A1 Process for the preparation of pantoprazole
09/28/2006WO2006100082A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
09/28/2006WO2006100081A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof
09/28/2006WO2006100080A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof
09/28/2006WO2006100036A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension
09/28/2006WO2006100026A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
09/28/2006WO2006099974A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
09/28/2006WO2006099943A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
09/28/2006WO2006099941A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
09/28/2006WO2006099810A1 Substituted sulfoxide compounds, methods for preparing the same and use thereof
09/28/2006WO2006077426A3 4- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS
09/28/2006WO2006076246A3 Phenylglycinamide derivatives useful as anticoagulants
09/28/2006WO2006073592A3 SALTS OF N-[2-({3R)-1-[trans-4-HYDROXY-4-(6-METHOXYPYRIDIN-3-YL)-CYCLOHEXYL]PYRROLIDINE-3-YL}AMINO)-2-OXOETHYL]-3-(TRIFLUOROMETHYL)BENZAMIDE
09/28/2006WO2006072608A3 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
09/28/2006WO2006071130A3 A process for preparation of imatinib base
09/28/2006WO2006053342A3 Integrin antagonists useful as anticancer agents
09/28/2006WO2006044975A3 Compositions and their use as anti-tumor agents
09/28/2006WO2006025979A3 Modulators of nuclear receptors
09/28/2006WO2005118567A3 Magnesium complexes of s-omeprazole